Cargando…
Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion
Vascular endothelial growth factor (VEGF) undergoes alternative splicing to produce both proangiogenic and antiangiogenic isoforms. Preferential splicing of proangiogenic VEGF is determined by serine-arginine protein kinase 1 (SRPK1), which is upregulated in a number of cancers. In the present study...
Autores principales: | Bullock, Nicholas, Potts, Jonathan, Simpkin, Andrew J, Koupparis, Anthony, Harper, Steve J, Oxley, Jon, Oltean, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752636/ https://www.ncbi.nlm.nih.gov/pubmed/26500332 http://dx.doi.org/10.1136/jclinpath-2015-203125 |
Ejemplares similares
-
SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER
por: Mavrou, Athina, et al.
Publicado: (2014) -
The many faces of SRPK1
por: Bullock, Nicholas, et al.
Publicado: (2017) -
Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions
por: Xu, Xiaotao, et al.
Publicado: (2017) -
Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
por: Duggan, William P., et al.
Publicado: (2022) -
Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
por: Caetano, Mônica Maria Magalhães, et al.
Publicado: (2022)